- New
Understanding diabetes and blood sugar after COVID‑19
Diabetes raises the risk of severe COVID-19, with some people reporting changes in blood sugar regulation after infection. Here’s what research suggests and how to know when to seek care.
Key takeaways
How does COVID-19 affect blood sugar regulation?
Does COVID-19 increase the risk of diabetes?
Temporary vs. ongoing blood sugar changes after COVID-19
Who may be at higher risk of changes to blood sugar regulation after COVID-19?
What symptoms or signs should I pay attention to?
How should blood sugar be monitored after COVID-19?
When should I talk to a doctor about diabetes concerns after COVID-19?
The relationship between COVID-19 and diabetes is complex and still being studied, but some people may experience changes after infection.
People living with diabetes are more likely to become seriously ill with COVID-19, and can experience more severe symptoms and complications after the initial illness.
For some people, including those who have never had diabetes before, a severe COVID-19 infection can increase blood sugar levels during and after infection. Studies have suggested that some adults, including those who experienced severe illness or hospitalization and those who are already managing other health conditions, can face an increased risk of being diagnosed with diabetes after contracting COVID-19. At the same time, the impact of COVID-19 on blood sugar levels can vary widely, and many people do not go on to develop lasting problems.
Changes to blood sugar regulation may be identified during follow‑up care or routine blood sugar testing. People who already have diabetes may notice that managing blood sugar feels different after COVID‑19. Research is still taking place to better understand why these changes occur in some individuals and not others.
Understanding how COVID-19 illness and recovery may affect blood sugar regulation, how short‑term and long-term changes can differ, who may be at higher risk, and when it may be helpful to talk with a healthcare provider can help you feel more informed and better prepared.
How does COVID-19 affect blood sugar regulation?
COVID-19 infection can affect how the body regulates blood sugar. During times of physical stress, blood sugar levels may temporarily increase as part of the response to illness.
Researchers have identified several reasons why COVID-19 may affect blood sugar regulation. The virus may directly affect the pancreas, which is the organ responsible for producing insulin. COVID-19 can also trigger an immune response that interferes with how the body uses insulin. In people treated with corticosteroids during severe COVID-19 illness, those medications can also contribute to temporary or lasting changes in blood sugar.
Changes in blood sugar levels can also occur after COVID-19, including persistent higher readings during recovery. Some people notice symptoms, while others do not experience any noticeable effects. Experiences vary widely, and there is no single pattern that applies to everyone.
Does COVID-19 increase the risk of diabetes?
Researchers are still studying the connection between COVID-19 and diabetes. In one analysis, the risk of newly diagnosed diabetes was higher in people who had COVID-19 compared to those who did not. In another study, researchers found that vaccinated individuals had lower risk of post-COVID diabetes.
60%
Higher risk of newly diagnosed diabetes
The risk of newly diagnosed diabetes is approximately 60% higher in people who had COVID-19 compared to those who did not.
Why might this happen? Some cases may be newly identified because people have more healthcare visits and lab testing after COVID‑19, and risk appears higher in those who had more severe illness. Research is still ongoing and more studies are needed to better understand examine the mechanisms that may explain this connection.
Many people recover from COVID-19 without developing diabetes or ongoing blood sugar concerns, however, for some, changes to blood sugar regulation can persist.
Temporary vs. ongoing blood sugar changes after COVID-19
After any significant illness, blood sugar can run higher for a period of time. For some people, those changes return to normal as recovery continues. For others, elevated blood sugar may persist and contribute to a new diagnosis, such as prediabetes or diabetes.
For people already living with diabetes, managing blood sugar (or glucose) may feel more challenging for a period after COVID-19 infection, and erratic glucose fluctuations have been documented in people with pre-existing Type 1 and Type 2 diabetes post-COVID.
Because blood sugar can fluctuate during recovery, monitoring patterns over time and discussing results with a healthcare provider can help clarify whether changes are temporary or ongoing. A single high reading might reflect short‑term stress on the body, while a pattern over weeks to months may suggest something that needs closer attention.
Who may be at higher risk of changes to blood sugar regulation after COVID-19?
Research points to a few groups that may be more likely to experience changes in blood sugar regulation after a COVID-19 infection:
- Those who experienced severe illness or hospitalization may be at higher risk of changes to blood sugar patterns.
- Those who are already managing other health conditions, including obesity, hypertension, cardiovascular conditions, and pre-existing metabolic disorders.
- Those with prediabetes or existing metabolic risk factors may be more at risk of metabolic changes following COVID‑19.
- Those already living with Type 1 or Type 2 diabetes.
Taking the COVID-19 risk assessment can help you understand whether you may be at increased risk for severe COVID-19, and support more informed next steps if you need care. Being higher risk does not necessarily mean blood sugar changes will occur, but understanding risk can help inform whether additional monitoring is recommended.
What symptoms or signs should I pay attention to?
Changes to blood sugar regulation don’t always cause clear or specific symptoms, especially early on. Some people may notice certain signals, such as:
- Feeling more fatigued than expected
- Increased thirst
- Needing to urinate more often
- Changes in appetite
- Blurred vision
Others may not notice symptoms at all, with changes identified only through routine blood tests.
It’s important to keep in mind that many of these signs can overlap with common post‑COVID-19 changes, such as ongoing tiredness, disrupted sleep, or changes in activity levels. This overlap can make symptoms hard to interpret on their own, and speaking to a healthcare provider can support your understanding.
How should blood sugar be monitored after COVID-19?
Monitoring depends on individual circumstances, including health history, symptoms, and whether changes are identified during routine care.
Monitoring may include blood tests during regular check-ups or follow-up appointments and can include home monitoring tools.
For people who have not previously been diagnosed with diabetes, a healthcare provider may recommend a fasting blood glucose test or an HbA1c (A1C) test, which reflects average blood sugar levels over the past 2–3 months. For those already managing diabetes, more frequent home monitoring or additional lab work may be recommended during and after COVID-19 recovery.
When and how often to check blood sugar levels is typically guided by individual needs and by your care team.
When should I talk to a doctor about diabetes concerns after COVID-19?
You do not need a diagnosis or severe symptoms to speak to a healthcare provider. It can be appropriate to book an appointment if:
- You develop new symptoms that could fit with high blood sugar, such as increased thirst or frequent urination
- You were hospitalized for COVID-19, since research suggests stronger links between severe illness and later diabetes diagnoses
- Higher readings or abnormal labs persist over several weeks
- Your A1C increases compared with your usual results, especially if the change is unexpected
Living with changes to blood sugar regulation after COVID-19
Noticing changes in blood sugar after COVID-19 can feel unexpected and difficult to navigate, especially if you have never had concerns about blood sugar before. For some, these changes are temporary and go away during recovery. For others, they may persist and require ongoing attention.
If you are already managing diabetes, staying in contact with your healthcare provider during and after COVID-19 recovery can help you track any changes, fine‑tune your blood sugar monitoring , and make any adjustments to your treatment plan as needed.
If you haven't been diagnosed with diabetes before but were told your blood sugar is higher after COVID-19, ask whether follow-up testing and ongoing monitoring is recommended, and how frequently. If you notice symptoms such as increased thirst, frequent urination, or unusual fatigue, book an appointment with a healthcare provider so they can help you develop a clear plan and discuss potential next steps.
Frequently
asked questions
Does COVID-19 cause diabetes?
Researchers are studying whether COVID-19 may be linked with a higher likelihood of diabetes after infection. Some studies have observed that more people receive a diabetes diagnosis following COVID-19, and emerging research is beginning to examine the specific mechanisms that may explain this connection, including effects on the pancreas and the role of inflammation. Research in this area is ongoing.
Can blood sugar go up after COVID-19?
Yes. Blood sugar levels can go up during or after COVID‑19, even in people who did not have diabetes before. These changes can be temporary and improve as recovery continues, but for some people they persist and may require follow-up.
Is high A1C after COVID-19 permanent?
Not always. Some people appear to have temporary changes in their A1C levels after COVID-19, while others may have ongoing, persistent elevation that needs follow-up. Testing A1C levels over time can help determine if there is a pattern.
Is diabetes part of Long COVID-19?
Long COVID can involve many body systems, and some research includes diabetes among conditions that may appear after infection in some people. Researchers are still learning why the risk of diabetes appears to be higher after severe disease.
When should I worry about blood sugar after COVID-19?
It’s helpful to speak with a healthcare provider if blood sugar readings stay higher than expected, changes persist, or new symptoms develop. You don’t need certainty about the cause or a prior diagnosis to start that conversation. Sharing what you are experiencing with a healthcare provider can help them determine whether any follow-up or monitoring is recommended.
More relevant articles
Keep reading
References
American Diabetes Association (ADA). Frequently Asked Questions: COVID-19 and Diabetes. Accessed April 20, 2026. https://diabetes.org/getting-sick-with-diabetes/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes.
American Diabetes Association (ADA). Warning Signs and Symptoms of Disease. Accessed May 11, 2026. https://diabetes.org/about-diabetes/warning-signs-symptoms
Centre for Evidence-Based Medicine (CEBM), University of Oxford. Coronavirus and diabetes: the different risks for people with type 1 and type 2. Published August 23, 2020. Accessed April 17, 2026. https://www.cebm.ox.ac.uk/news/views/coronavirus-and-diabetes-the-different-risks-for-people-with-type-1-and-type-2
Cruz Neto J, Fiuza Olivindo CV, Guimarães Dos Santos JA, Araujo da Silva MA, de Oliveira Sales Junior R. Cardiometabolic factors related to post-COVID-19 conditions: a scoping review. Revista Cuidarte. 2025;16(2). doi:10.15649/cuidarte.4290
Fang H, Wang Q. The silent epidemic within the pandemic: pathophysiology and prediction of post-COVID-19 diabetes. J Transl Med. 2026;24(1):266. doi:10.1186/s12967-026-07717-x
Floyd JS, Walker RL, Kuntz JL, et al. Association Between Diabetes Severity and Risks of COVID-19 Infection and Outcomes. J Gen Intern Med. 2023;38(6):1484-1492. doi:10.1007/s11606-023-08076-9
Gerganova A, Assyov Y, Kamenov Z. Stress hyperglycemia, diabetes mellitus and covid-19 infection: risk factors, clinical outcomes and post-discharge implications. Front Clin Diabetes Healthc. 2022;3:826006. doi:10.3389/fcdhc.2022.826006
Hsieh, T. Y. J., Chang, R., Yong, S. B., Liao, P. L., Hung, Y. M., & Wei, J. C. (2023). COVID-19 Vaccination Prior to SARS-CoV-2 Infection Reduced Risk of Subsequent Diabetes Mellitus: A Real-World Investigation Using U.S. Electronic Health Records. Diabetes care, 46(12), 2193–2200. https://doi.org/10.2337/dc23-0936
Kim SH, Arora I, Hsia DS, et al. New-onset diabetes after covid-19. The Journal of Clinical Endocrinology & Metabolism. 2023;108(11):e1164-e1174. doi:10.1210/clinem/dgad284
National Institute of Diabetes and Digestive and Kidney Disease. The A1C Test & Diabetes. Accessed May 11, 2026. https://www.niddk.nih.gov/health-information/diagnostic-tests/a1c-test#whatis
Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Annales d’Endocrinologie. 2020;81(2-3):101-109. doi:10.1016/j.ando.2020.05.001
Rizvi AA, Kathuria A, Al Mahmeed W, et al. Post-COVID syndrome, inflammation, and diabetes. Journal of Diabetes and its Complications. 2022;36(11):108336. doi:10.1016/j.jdiacomp.2022.108336
Steenblock C, Hassanein M, Khan EG, et al. Diabetes and covid-19: short- and long-term consequences. Horm Metab Res. 2022;54(08):503-509. doi:10.1055/a-1878-9566
Vedantam D, Poman DS, Motwani L, Asif N, Patel A, Anne KK. Stress-induced hyperglycemia: consequences and management. Cureus. Published online July 10, 2022. doi:10.7759/cureus.26714
Wong R, Lam E, Bramante CT, et al. Does covid-19 infection increase the risk of diabetes? Current evidence. Curr Diab Rep. 2023;23(8):207-216. doi:10.1007/s11892-023-01515-1
Zhao X, Jiang L, Sun W, et al. Understanding the interplay between COVID-19 and diabetes: insights for the post-pandemic era. Front Endocrinol. 2025;16:1599969. doi:10.3389/fendo.2025.1599969
Zhou J, Wang Y, Xu R. Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis. Front Endocrinol. 2024;15:1429848. doi:10.3389/fendo.2024.1429848